Background: Accurate detection of organisms producing extended-spectrum β-lactamase (ESBL) and AmpC β-lactamase is very important for treatment of patients. However, unlike the ESBL confirmatory test, there are no guidelines for detection of organisms producing AmpC β-lactamase. We evaluated a detection method using boronic acid (BA) for ESBL and AmpC β-lactamase. Methods: Clinical isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, and Proteus mirabilis showing intermediate resistance or resistance to cefoxitin (FOX) or positive for ESBL were tested. A ≥5 mm increase in zone diameter of ceftazidime/clavulanic acid/BA (CAZ/CA/BA) and/or cefotaxime/clavulanic acid/BA (CTX/CA/BA) versus CAZ/BA and/or CTX /BA was considered positive for ESBL. Likewise, a ≥5 mm increase in zone diameter of FOX/BA and/or cefotetan/BA (CTT/BA) versus FOX and/or CTT alone was considered positive for AmpC β-lactamase.
. Representative results using the Clinical and Laboratory Standards Institute extended-spectrum β-lactamase (ESBL) confirmatory test and AmpC disk test without and with boronic acid (two disks positioned in right side on media). Abbreviations: FOX, cefoxitin; CAZ, ceftazidime; CV, clavulanic acid; CTX, cefotaxime; CTX, cefotaxime. Left media shows AmpC positive, center media shows ESBL positive, and right media shows that isolate is negative in CLSI method and positive in boronic acid disk. 
